Home » Headlines » Currently Reading:

Morning Headlines 4/7/17

April 6, 2017 Headlines No Comments

23andMe, Inc. Granted First FDA Authorization to Market Direct-to-Consumer Genetic Health Risk Reports

More than three years after being shut down by the FDA for selling genetic health risk reports to consumers without clearance, 23andMe finally receives the FDA’s approval to resume sales. The approval covers reports on personal risk for ten conditions, including late-onset Alzheimer’s disease, Parkinson’s disease, and celiac disease.

Highly confidential psychotherapy records from Maine center listed on the dark web

A mental health center in Maine reports that 4,500 patient records have been stolen by hackers and offered for sale on the dark web. The records include highly-sensitive information, including names, addresses, social security numbers, medial histories, and full session notes.

SAFER Guides

ONC updates its SAFER Guides, a series of guides designed to help healthcare organizations address EHR safety issues.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Good for the blokes at Craneware. If you’re going to sell your company to be over-leveraged and sold-off piecemeal, leaving…

  2. Yes. And Epic also takes part in Carequality and TEFCA, two other methods for sharing info between hospitals on other…

  3. So that is in real time while a patient is at another facility that is non-Epic or not connected?

  4. Seriously. It’s even easier for the government to get Epic/EHR vendors to do things. “If you want to accept Medicaid/Medicare…

  5. A few years ago there was a situation where the FBI had possession of a locked and encrypted iPhone that…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.